Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02448966
What this trial is testing

Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 1,000
Not applicableStudy completedNCT04859595
What this trial is testing

Follow-up After a Stay in Intensive Rehabilitation for Patients With Swallowing Disorders

Who this might be right for
Swallowing Disorders
University Hospital, Toulouse 35
Not applicableLooking for participantsNCT06558786
What this trial is testing

Registry for Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal-junction CancerEsophageal Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT01774851
What this trial is testing

MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Who this might be right for
HER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more
Merrimack Pharmaceuticals 84
Not applicableStudy completedNCT02385929
What this trial is testing

Pre-habilitation of Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Irene Wessel 240
Large-scale testing (Phase 3)Ended earlyNCT01697072
What this trial is testing

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Amgen 609
Not applicableNot Yet RecruitingNCT06879483
What this trial is testing

Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sohag University 30
Large-scale testing (Phase 3)Study completedNCT00359645
What this trial is testing

Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population

Who this might be right for
Pharynx CancerLarynx CancerOral Cavity Cancer+1 more
Gustave Roussy, Cancer Campus, Grand Paris 1,993
Large-scale testing (Phase 3)Study completedNCT00160875
What this trial is testing

Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
University Health Network, Toronto 54
Testing effectiveness (Phase 2)Ended earlyNCT03301454
What this trial is testing

Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer, Squamous Cell
Centre Oscar Lambret 15
Not applicableStudy completedNCT03448341
What this trial is testing

Dysphagia Assessment After Swallowing Sparing RadioTherapy

Who this might be right for
Cancer of OropharynxCancer of Nasopharynx
Azienda Ospedaliero, Universitaria Pisana 74
Not applicableNot Yet RecruitingNCT07343869
What this trial is testing

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

Who this might be right for
Superficial Esophageal CancerOesophageal AdenocarcinomaOesophageal Squamous Cell Carcinoma+1 more
Société Française d'Endoscopie Digestive 750
Not applicableNot Yet RecruitingNCT06756841
What this trial is testing

Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Energenx Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT06010303
What this trial is testing

Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerEsophageal Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma by AJCC V8 Stage
BeiGene 118
Not applicableActive Not RecruitingNCT04878783
What this trial is testing

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

Who this might be right for
Gastric CancerAdenocarcinoma of the Stomach
University of Roma La Sapienza 138
Not applicableStudy completedNCT04773080
What this trial is testing

Incidence, Risk Factors and Consequences of Acute Kidney Injury in Patients Undergoing Esophageal Cancer Surgery

Who this might be right for
Acute Kidney InjuryPostoperative Complications
Azienda Ospedaliera di Padova 254
Testing effectiveness (Phase 2)Looking for participantsNCT07188103
What this trial is testing

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 37
Not applicableStudy completedNCT02158286
What this trial is testing

Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet

Who this might be right for
Esophageal and/or Cardia CancerEsophagectomyGastric Pull-up Reconstruction
Region Skane 13
Not applicableActive Not RecruitingNCT07022886
What this trial is testing

INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE

Who this might be right for
Achalasia CardiaEsophageal Cancer (EsC)
IRCCS San Raffaele 47,000
Testing effectiveness (Phase 2)Study completedNCT04207918
What this trial is testing

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyNimotuzumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Next Page